Fontenay aux Roses, France

R Egine Bartsch

This inventor holds 2 USPTO granted patents. Top assignee: Synthelabo. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Egine Bartsch. Retrieved from https://idiyas.com/inventor/r-egine-bartsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: R Egine Bartsch: Innovator in Cerebral Disorder Treatments

Introduction

R Egine Bartsch is a notable inventor based in Fontenay aux Roses, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cerebral disorders. With a total of 2 patents, Bartsch's work is recognized for its potential impact on medical science.

Latest Patents

Bartsch's latest patents include innovative compounds aimed at addressing cerebral disorders. One of his patents is for 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4, which features a complex formula designed to treat and prevent various cerebral conditions. Another patent involves N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide, which also targets cerebral disorders through its unique chemical structure.

Career Highlights

Throughout his career, Bartsch has been associated with Synthelabo, a company known for its advancements in pharmaceutical research. His work has contributed to the development of new treatments that could improve the quality of life for individuals suffering from cerebral disorders.

Collaborations

Bartsch has collaborated with notable colleagues such as Jonathan Reid Frost and Pascal George. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

R Egine Bartsch's contributions to the treatment of cerebral disorders through his patents and collaborations highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…